Panagora Asset Management Inc Concert Pharmaceuticals, Inc. Transaction History

Panagora Asset Management Inc

$20.5 Billion
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 11, 2021	SELL	$3.77 - $5.24 $95,471 - $132,697	-25,324 Closed	0 $0
Q1 2021 May 12, 2021	BUY	$4.86 - $13.07 $5,885 - $15,827	1,211 Added 5.02%	25,324 $126,000
Q4 2020 Feb 10, 2021	BUY	$9.48 - $12.84 $45,039 - $61,002	4,751 Added 24.54%	24,113 $305,000
Q3 2020 Nov 13, 2020	SELL	$8.67 - $10.82 $88,113 - $109,963	-10,163 Reduced 34.42%	19,362 $190,000
Q2 2020 Aug 12, 2020	SELL	$7.8 - $11.52 $210,904 - $311,489	-27,039 Reduced 47.8%	29,525 $294,000
Q1 2020 May 14, 2020	SELL	$5.98 - $13.09 $1.02 Million - $2.24 Million	-170,836 Reduced 75.13%	56,564 $500,000
Q4 2019 Feb 12, 2020	BUY	$5.71 - $9.22 $155,260 - $250,701	27,191 Added 13.58%	227,400 $2.1 Million
Q3 2019 Nov 12, 2019	SELL	$5.88 - $12.35 $194,833 - $409,217	-33,135 Reduced 14.2%	200,209 $1.18 Million
Q2 2019 Aug 09, 2019	BUY	$9.44 - $13.12 $954,874 - $1.33 Million	101,152 Added 76.52%	233,344 $2.8 Million
Q1 2019 May 15, 2019	BUY	$12.07 - $17.54 $104,852 - $152,369	8,687 Added 7.03%	132,192 $1.6 Million
Q4 2018 Feb 14, 2019	SELL	$11.25 - $16.17 $329,771 - $473,991	-29,313 Reduced 19.18%	123,505 $1.55 Million
Q3 2018 Nov 13, 2018	SELL	$12.82 - $17.88 $1.04 Million - $1.45 Million	-81,288 Reduced 34.72%	152,818 $2.27 Million
Q2 2018 Aug 14, 2018	BUY	$16.83 - $21.66 $1.93 Million - $2.49 Million	114,905 Added 96.4%	234,106 $3.94 Million
Q1 2018 May 15, 2018	BUY	$19.24 - $28.03 $1.58 Million - $2.3 Million	81,981 Added 220.26%	119,201 $2.73 Million
Q4 2017 Feb 14, 2018	BUY	$13.96 - $29.05 $519,591 - $1.08 Million	37,220	37,220 $963,000

Others Institutions Holding CNCE

# of Institutions

Shares Held

Call Options Held

Put Options Held

Concourse Financial Group Securities, Inc. Birmingham, AL

0
Shares

$0
0.0% of portfolio

View Full List

About CONCERT PHARMACEUTICALS, INC.

Ticker CNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,934,600
Description
Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company's lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has s...

More about CNCE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Panagora Asset Management Inc with notifications on news.

Account